`
`Fauci says U.S. vaccinations to increase in spring as
`Biden administration nears doses goal
`
`By
`Reis Thebault
`
`Feb. 7, 2021 at 7:14 p.m. EST
`
`Public health officials and experts injected some optimism into a dreary cycle of news about the coronavirus pandemic in the
`United States on Sunday, sounding hopeful about the springtime availability of vaccines and doses.
`
`Anthony S. Fauci, the nation’s highest-ranking infectious-diseases doctor, acknowledged that the demand for vaccinations
`“clearly outstrips supply right now,” but he said he expects the situation to improve in the coming months.
`
`“I can tell you that things are going to get better as we get from February into March, into April, because the number of vaccine
`doses that will be available will increase substantially,” Fauci said on NBC’s “Meet the Press.”
`
`He said the stock will come from two sources: the already approved Pfizer and Moderna vaccines, which he said are “coming
`off the line as quickly as we can”; and a vaccine from Johnson & Johnson, which submitted the single-shot drug to U.S.
`regulators on Thursday.
`
`
`
`Full Fauci Interview: Vaccine Shortages 'A Supply-Demand Issue' | Meet The Press | NBFull Fauci Interview: Vaccine Shortages 'A Supply-Demand Issue' | Meet The Press | NB……
`
`Fauci’s forecast comes as the United States vaccinates more people each day. On Saturday, states administered nearly 2
`million doses, according to Washington Post data. That round of shots increased the country’s daily average to 1.4 million, just
`shy of the 1.5 million-per-day goal President Biden floated on the sixth day of his administration.
`
`Bid
`
`i d
`
`hi
`
`id
`
`h
`
`h
`
`id “I thi k
`
`ith th
`
`f G d
`
`d th
`
`d ill
`
`f th
`
`i hb
`
`/
`d
`
`Koss 2016
` IPR2021-00297
`
`
`
`Biden surprised many, even his own aides, when he said: “I think, with the grace of God, and the goodwill of the neighbor, and
`the creek not rising, as the old saying goes, I think we may be able to get that to 1.5 million a day.”
`
`But the country is still in a dark place. Even though the number of new infections has been declining steadily for nearly a
`month, the current average — more than 120,000 cases per day — far outpaces the surges seen in the spring and summer. And
`still, covid-19, the disease caused by the virus, is killing thousands of Americans each day.
`
`Virus variants have made matters more dire. Research made public Sunday found that the strain first detected in the United
`Kingdom is spreading rapidly across the United States, doubling in prevalence every 10 days — and even faster in Florida, the
`third most populous state.
`
`The Centers for Disease Control and Prevention has estimated that the variant, known as B.1.1.7, will become dominant in the
`United States by late March.
`
`The virus variant’s swift spread has intensified pressure on the effort to vaccinate as many people as possible, as fast as
`possible. One approach that experts in the United States and abroad have suggested is to use all available vaccine supply on
`first doses, giving a wider pool of people at least partial protection and delaying the second dose, which boosts the vaccines’
`effectiveness.
`
`Michael Osterholm, one of Biden’s coronavirus advisers, has said the strategy deserves further consideration. But on Sunday
`morning, Fauci said that there’s no time to study it and that the country is better off sticking to the two-dose rollout that was
`the subject of clinical trials.
`
`“It’s a reasonable idea,” Fauci said. “I’m not putting the idea down. But it’s very impractical to do, it really is.”
`
`On Twitter, Scott Gottlieb, a former commissioner of the Food and Drug Administration, echoed Fauci’s optimism about the
`country’s increasing supply of vaccines, but said leaders may then face another problem: more doses than people willing to
`receive them.
`
`“I think it’s possible that by April, supply could outstrip demand,” Gottlieb said. “We should start to focus now on that
`challenge.”
`
`Annie Gowen and Jacqueline Dupree contributed to this report.
`
`/
`
`Koss 2016
` IPR2021-00297
`
`